V. Bavetsias et al., QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - GAMMA-LINKEDL-D, D-D, AND D-L DIPEPTIDE ANALOGS OF -DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583), Journal of medicinal chemistry, 39(1), 1996, pp. 73-85
The syntheses of gamma-linked L-D, D-D, and D-L dipeptide analogues of
-desamino-2-methyl-N-10-propargyl-5,8-dideazafolic acid (ICI 198583)
are described. The general methodology for the synthesis of these mole
cules involved the preparation of the dipeptide derivatives employing
solution phase peptide synthesis followed by condensation of the dipep
tide free bases with the appropriate pteroic acid analogue via diethyl
cyanophosphoridate (DEPC) activation. In the final step, tert-butyl e
sters were removed by trifluoroacetic acid (TFA) hydrolysis. Z-L-Glu-O
Bu(t)-gamma-D-Ala-OBu(t), for example, was prepared from alpha-tert-bu
tyl N-(benzyloxycarbonyl)-L-glutamate and tert-butyl D-alaninate via i
sobutyl-mixed anhydride coupling. The Z-group was removed by catalytic
hydrogenolysis and the resulting dipeptide free base condensed with d
esamino-2-methyl-N-10-propargyl-5,8-didezapteroic acid via DEPC coupli
ng. Finally, tert-butyl esters were removed by TFA hydrolysis to give
ICI 198583-gamma-D-Ala. The compounds were tested as inhibitors of thy
midylate synthase and L1210 cell growth. Good enzyme and growth inhibi
tory activity were found with gamma-linked L-D dipeptides, the best ex
amples being the Glu-gamma-D-Glu derivative 35 (K-i = 0.19 nM, L1210 I
C50 = 0.20 +/- 0.017 mu M) and the Glu-gamma-D-alpha-aminoadipate deri
vative 39 (K-i = 0.12 nM, L1210 IC50 = 0.13 +/- 0.063 mu M). In additi
on, ICI 198583 L-gamma-D-linked dipeptides were resistant to enzymatic
degradation in mice.